QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation 期刊论文 MOLECULAR CANCER THERAPEUTICS, 2021, 卷号: 20, 期号: 11, 页码: 2198-2206 作者:  Jiang, Yuchen;  Peng, Xia;  Ji, Yinchun;  Dai, Yang;  Fang, Yanfen 收藏  |  浏览/下载：31/0  |  提交时间：2021/12/16 Palladium-Catalyzed, Silver-Assisted Direct C-5-H Arylation of 3-Substituted 1,2,4-Oxadiazoles under Microwave Irradiation 期刊论文 ADVANCED SYNTHESIS & CATALYSIS, 2017, 卷号: 359, 期号: 5, 页码: 772-778 作者:  Li, Shan;  Wan, Penghui;  Ai, Jing;  Sheng, Rong;  Hu, Yongzhou 收藏  |  浏览/下载：24/0  |  提交时间：2019/01/08 C-H activation  concerted metalation-deprotonation (CMD) pathway  3,5-diaryl-1,2,4-oxadiazoles  1,2,4-oxadiazoles   Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 126, 页码: 122-132 作者:  Liu, Yang;  Peng, Xia;  Guan, Xiaocong;  Lu, Dong;  Xi, Yong 收藏  |  浏览/下载：44/0  |  提交时间：2019/01/08 FGFR  KDR  Inhibitor  Anticancer  Ponatinib   Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl) benzamides as novel RET kinase inhibitors 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 卷号: 26, 期号: 23, 页码: 5679-5684 作者:  Han, Mei;  Li, Shan;  Ai, Jing;  Sheng, Rong;  Hu, Yongzhou 收藏  |  浏览/下载：21/0  |  提交时间：2019/01/08 RET kinase inhibitor  1,2,4-Oxadiazole  Anti-cancer therapy   Design and synthesis of novel benzo[d]oxazol-2(3H)-one derivatives bearing 7-substituted-4-enthoxyquinoline moieties as c-Met kinase inhibitors 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 115, 页码: 191-200 作者:  Lu, Dong;  Shen, Aijun;  Liu, Yang;  Peng, Xia;  Xing, Weiqiang 收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 c-Met  Benzo[d]oxazol-2(3H)-one-quinolone  Molecular hybridization  Anti-cancer   Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 108, 页码: 322-333 作者:  Liu, Yang;  Jin, Shiyu;  Peng, Xia;  Lu, Dong;  Zeng, Limin 收藏  |  浏览/下载：14/0  |  提交时间：2019/01/08 Pyridazinone  c-Met inhibitor  Cyclization strategy  Antitumor   Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 卷号: 95, 页码: 302-312 作者:  Xing, Weiqiang;  Ai, Jing;  Jin, Shiyu;  Shi, Zhangxing;  Peng, Xia 收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 Pyridazinone  c-Met inhibitor  Anticancer  Docking study   yhhu3813isanovelselectiveinhibitorofcmetkinasethatinhibitscmetdependentneoplasticphenotypesofhumancancercells 期刊论文 actapharmacologicasinica, 2014, 卷号: 000, 期号: 001, 页码: 89 作者:  He Changxi;  Ai Jing;  Xing Weiqiang;  Chen Yi;  Zhang Haotian 收藏  |  浏览/下载：13/0  |  提交时间：2020/07/01 选择性抑制剂  抗肿瘤特性  激酶活性  癌细胞  依赖性  人类  表型  Western印迹